Category - Congress

Amneal Pharmaceuticals Books Capitol Hill Congress FDA Food and Drug Administration Government Guest Contributor Guest Contributors India Section 3(d) innovation intellectual property International Inventors Information IP News IPWatchdog Articles Legislation Lindsey Graham No Combination Drug Patents Act patent Patent Reform Patentability Patents pharmaceutical innovation Senate Judiciary Committee technology Technology & Innovation TRIPS

Say No to No Combination Drug Patents Act

“Economically, incremental innovation within the pharmaceutical business delivers value financial savings. Incremental improvements are often launched at a...

Books CAFC Capitol Hill Congress Courts Federal Circuit Government Guest Contributor Guest Contributors independent inventor independent inventors innovation intellectual property inventor Inventors Information IP News IPWatchdog Articles Legislation Litigation patent patent eligibility patent eligible patent office patent prosecution Patent Reform Patents SCOTUS technology Technology & Innovation US Supreme Court USPTO

Arguing Device-and-Method Eligibility Under the Present and Future States of U.S. Patent Law

“Contemplating the innumerable ways in which the problems might play out, your aim should be to make a report displaying that your shopper’s claimed material...

autm Bayh-Dole Books Business Capitol Hill Congress Department of Defense drug pricing Frederick Reinhart Government Guest Contributor Guest Contributors innovation intellectual property International IP News IPWatchdog Articles james love Japan Knowledge Ecology International Legislation Licensing NIH NIST patent Patent Reform Patents technology Technology & Innovation

Jamie Love Responds to Criticism of Knowledge Ecology International Letter

“Reinhart and AUTM are arguing that ‘obtainable to the general public on affordable phrases’ doesn’t imply the worth needs to be affordable. We disagree...